Skip to main content
Clinical Trials/NCT04137445
NCT04137445
Recruiting
Not Applicable

The Effects of Early Complementary Feeding on Growth, Neurodevelopment, Sleep and Gut Health

University of Colorado, Denver1 site in 1 country100 target enrollmentMarch 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Linear Growth
Sponsor
University of Colorado, Denver
Enrollment
100
Locations
1
Primary Endpoint
Weight
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The overall objective of this project is to understand how consuming a prescribed diet of different infant foods (which may contain cereals,fruits, vegetables, meats, dairy) during the time of early complementary feeding (~5 to 12 months) in breastfed infants has on growth trajectories, neurodevelopment and sleep patterns in relation to gut microbiota, compared with a traditional diet that is usually provided in the home to infants.

The three primary aims include:

Aim 1: Identify the effects that the prescribed early complementary feeding specific study diet has on growth trajectories in breastfed infants.

Aim 2: Identify whether the relationship between the prescribed early complementary feeding specific study diet and growth is mediated by gut microbiota.

Aim 3: Characterize infant neurodevelopment and sleep patterns.

Detailed Description

Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.

Registry
clinicaltrials.gov
Start Date
March 15, 2020
End Date
June 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Full term: gestational age \> 37 weeks
  • Exclusively breastfed (\< 2 weeks of cumulative formula exposure). Any formula consumption on a given day is considered one day of formula exposure. During the intervention, if the participant receives more than 50% of the liquid diet from infant formula, s/he will be excluded from the study.
  • Maternal conditions such as gestational diabetes mellitus, preeclampsia, multiple pregnancies are acceptable.

Exclusion Criteria

  • Large for gestational age or small for gestational age
  • Antibiotic use from birth to the time of enrollment
  • Documented food allergies
  • Previous complementary food exposure
  • Conditions that would affect protein metabolism or growth

Outcomes

Primary Outcomes

Weight

Time Frame: Over 6 months

Measured in kg

Length

Time Frame: Over 6 months

Measured in cm

Gut Microbiome

Time Frame: Over 6 months

Gut microbiota structure by 16S sequencing

Secondary Outcomes

  • Total calories in breast milk(Over 6 months)
  • Neurodevelopment(At 12 months of age)
  • Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)(Over 6 months)
  • Total protein in breast milk(Over 6 months)
  • Body composition(Over 6 months)
  • Dietary intake(Over 6 months)
  • Duration of sleep(Over 6 months)
  • Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)(Over 6 months)
  • Serum c-reactive protein (CRP-hs)(Over 6 months)
  • Total carbohydrates in breast milk(Over 6 months)
  • Total fat in breast milk(Over 6 months)

Study Sites (1)

Loading locations...

Similar Trials